Daclatasvir plus asunaprevir in the treatment of uremic patients with chronic hepatitis C genotype 1b infection
- PMID: 32087891
- DOI: 10.1016/j.kint.2019.10.033
Daclatasvir plus asunaprevir in the treatment of uremic patients with chronic hepatitis C genotype 1b infection
Comment in
-
The authors reply.Kidney Int. 2020 Mar;97(3):615. doi: 10.1016/j.kint.2019.11.033. Kidney Int. 2020. PMID: 32087890 No abstract available.
Comment on
-
Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.Kidney Int. 2018 Oct;94(4):663-673. doi: 10.1016/j.kint.2018.06.011. Kidney Int. 2018. PMID: 30243313
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical